End Stage Renal Disease Clinical Trial
American hemodialysis patients are frequently malnourished. This contributes to dialysis
patient mortality rates that are the highest in the industrialized world at 22% per year.
Poor nutritional status probably also contributes to high health care costs (an average of
two hospitalizations annually per patient and total Medicare expenditures of $11 billion per
year) and diminished quality of life. The researchers' prior work identified several
potentially modifiable nutritional barriers (e.g. poor appetite, inadequate dialysis dose,
poor nutritional knowledge, low fluid intake, and needing help shopping and cooking) and
pilot tested a promising approach to overcome these barriers.
This proposed community-based randomized controlled trial extends the researchers' prior
work by targeting specific nutritional barriers with a tailored feedback and education
intervention. Approximately 40 dialysis facilities in northeast Ohio will be randomly
assigned to intervention and control groups, with approximately 100 malnourished patients
enrolled from 20 intervention facilities and 100 from 20 control facilities. Baseline
evaluation will include measures of nutritional status, specific barriers, inpatient
expenditures, and quality of life. On a monthly basis for 12 months, intervention patients
and their dietitians will receive tailored feedback and education on overcoming
patient-specific barriers. They will then meet monthly to jointly formulate a care plan
addressing these barriers. Control patients will continue to get usual care. Major analyses
will compare changes in nutritional parameters in intervention vs. control patients with
adjustment for nesting of patients within facilities.
The proposed project will test a novel intervention that targets patients and providers as
they together make nutrition-related decisions. Overcoming specific barriers may lead not
only to improved nutritional status but also to better patient survival, decreased health
care costs, and increased quality of life.
| Status | Completed |
| Enrollment | 0 |
| Est. completion date | October 2004 |
| Est. primary completion date | |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Most recent albumin and mean albumin over last 3 months <3.7 g/dL by bromcresol green method (or <3.4 g/dL by bromcresol purple method) - Age greater than or equal to 18 years - On chronic hemodialysis at least 9 months Exclusion Criteria: - Mentally incompetent - Cirrhosis - AIDS - Cancer - Terminal illness - Malabsorption - Receiving total parenteral nutrition |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Case Western Reserve University |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in albumin | |||
| Primary | Change in albumin of 0.20 or greater and survival | |||
| Secondary | Change in subjective global assessment, weight, dietary intake, specific nutritional barriers |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04076488 -
Feasibility of an Interactive Tablet-based Exercise Program for People With Chronical Diseases
|
N/A | |
| Completed |
NCT03289650 -
Extended Release Tacrolimus vs. Twice-Daily Tacrolimus
|
Phase 3 | |
| Completed |
NCT04042324 -
A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients
|
Phase 1/Phase 2 | |
| Completed |
NCT01242904 -
Use of a Bimodal Solution for Peritoneal Dialysis
|
Phase 2 | |
| Active, not recruiting |
NCT03183245 -
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis
|
Phase 3 | |
| Completed |
NCT03257410 -
Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients
|
N/A | |
| Completed |
NCT03627299 -
Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors
|
Phase 4 | |
| Recruiting |
NCT05917795 -
Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
|
N/A | |
| Terminated |
NCT03539861 -
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
|
N/A | |
| Withdrawn |
NCT02130817 -
Belatacept in Kidney Transplantation of Moderately Sensitized Patients
|
Phase 4 | |
| Completed |
NCT05540457 -
Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)
|
N/A | |
| Not yet recruiting |
NCT04900610 -
The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis
|
N/A | |
| Recruiting |
NCT02176434 -
Pilot Feasibility Study of Combined Kidney and Hematopoietic Stem Cell Transplantation to Cure End-stage Renal Disease
|
N/A | |
| Active, not recruiting |
NCT02581449 -
Effect of Omega-3 Fatty Acids on Oxidative Stress and Dyslipidemia in Pediatric Patients Undergoing Hemodialysis
|
Phase 2 | |
| Completed |
NCT02134314 -
C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI
|
Phase 1/Phase 2 | |
| Completed |
NCT02832466 -
Quantifying the Deterioration of Physical Function in Renal Patients
|
N/A | |
| Completed |
NCT02830490 -
Reliability of Functional Measures in Hemodialysis Patient.
|
N/A | |
| Completed |
NCT02832440 -
Comparison of Two Exercise Programmes in Patients Undergoing Hemodialysis
|
N/A | |
| Completed |
NCT02215655 -
Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence
|
N/A | |
| Recruiting |
NCT01912001 -
Virtual Ward for Home Dialysis
|
N/A |